Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9de32f6289dcf304fcf935f042feceae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate |
2005-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_650cefe5f2ac5d4ed5c2734cfe2e896e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_613dbea1500e903ea1437766aaed68ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5b5dfd5611ed6a1a1389892b1c01a4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_762b8428b32e21888a216c21cff3cc18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbdbb53260ac688b311c33e814c89dbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2511a3383a3db027ec420097c92759ce |
publicationDate |
2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2705586-T3 |
titleOfInvention |
Prevention and treatment of synucleinopic and amyloidogenic diseases |
abstract |
An antibody that specifically binds to an epitope within residues 1-10 of human alpha-synuclein, the residues being numbered according to SEQ ID NO: 1, for use in therapy. |
priorityDate |
2004-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |